The Tiny Vaccine Lab With a $10 Million Head Start - and No Human Trial Yet

TechnoVax has spent two decades making convincing copies of dangerous viruses - minus the genes that make them dangerous. Its science has attracted roughly $10 million in federal awards; the harder experiment is turning a tiny lab's preclinical wins into a product people can actually receive.